Anti-angiogenic and cytotoxic evaluation of green-synthesized [Fe.sub.2]Zn[O.sub.4] nanoparticles against MCF-7 cell line

The use of plants for nanoparticle (NP) synthesis, grounded in green chemistry principles, is an environmentally friendly and economically viable approach. In the present study, the leaf extract of Elaeagnus angustifolia L. was used as a biosynthetic agent to generate bimetallic zinc oxide NPs. The...

Full description

Saved in:
Bibliographic Details
Published inBiomedical reports Vol. 20; no. 3; p. 1
Main Authors Al-Zabin, Asma, Thiab, Tuqa Abu, Zihlif, Malek, Al-Hunaiti, Afnan, J. Al-Ameer, Hamzeh, Al-Awaida, Wajdy, Imraish, Amer
Format Journal Article
LanguageEnglish
Published Spandidos Publications 01.03.2024
Subjects
Analysis
Biological products
Computer software industry
Diffraction
Ferric oxide
Green chemistry
Infrared spectroscopy
Medicine, Botanic
Medicine, Herbal
X-rays
Zinc oxide
United States
Online AccessGet full text

Cover

More Information
Summary:The use of plants for nanoparticle (NP) synthesis, grounded in green chemistry principles, is an environmentally friendly and economically viable approach. In the present study, the leaf extract of Elaeagnus angustifolia L. was used as a biosynthetic agent to generate bimetallic zinc oxide NPs. The present study investigated the effect of ZnO NPs on anti-angiogenesis and cell migration. Various bimetallic NPs, including zinc-iron oxide and nickel-zinc oxide, underwent characterization through Fourier-transform infrared spectroscopy and X-ray Diffraction within the 25-65[degrees] range. Confirmation of NP formation was determined by identifying the surface plasmon resonance peak. MTT assay was used to determine the cytotoxic properties of E. angustifolia L. extracts, ZnO NPs and associated metals in MCF-7 breast cancer cells. The plant extract demonstrated antiproliferative effects at 200 [micro]g/ml, whereas E. ang-[Fe.sub.2]Zn[O.sub.4] NPs showed varying cytotoxic effects based on concentration. The rat aortic ring and cell migration assays illuminated anti-angiogenic attributes, with the E. ang-[Fe.sub.2]Zn[O.sub.4] NPs blocking blood vessel development entirely at 100 [micro]g/ml, implying profound anti-angiogenic efficacy. Therefore, E. ang-[Fe.sub.2]Zn[O.sub.4] NPs may serve a role in antiangiogenic therapy.
ISSN:2049-9434
2049-9442
DOI:10.3892/br.2024.1724